This article has been updated from a previous version, which incorrectly identified Asuragen as an ABI subsidiary. The details of ABI's acquisition of Ambion have also been corrected. 
 
NEW YORK (GenomeWeb News) — Illumina today said it has certified Asuragen as a gene expression profiling services provider for its Human-6 Expression BeadChip.
 
Illumina has also certified DeCode Genetics to use its Infinium BeadChip genotyping platform.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.

Oct
17
Sponsored by
Lexogen

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.